Strongbridge Biopharma (SBBP) Survey Gives 4 Reasons To Stay Bullish - Oppenheimer

August 14, 2018 7:20 AM

Oppenheimer analyst, Hartaj Singh, reiterated his Outperform rating on shares of Strongbridge Biopharma (NASDAQ: SBBP) and raised the price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found